Biopharma Insights - page 9

13 Foundation Models: Startups, Industry Updates and the Nobel Prize

Since our previous overview of foundation models and start-ups in the life science field, a historical event took place on October 9th, 2024: the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John …

Continue ›››

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

A new industry report from PicnicHealth reveals that nearly 80% of life sciences leaders are open to using virtual models to improve observational research, citing ongoing challenges with data completeness …

Continue ›››

12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials

Despite undeniable progress in life sciences over the last few decades, modern healthcare faces challenges on many fronts. Lengthy drug development processes, often spanning 10 to 15 years, suboptimal clinical …

Continue ›››

Next Generation Sequencing: New Tech and Companies to Watch

From the discovery of the double helix to the latest AI-driven innovations. In this article: Roche’s NGS Trajectory — Sequencing History — NGS in Healthcare — Notable Recent NGS Events — …

Continue ›››

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

Pharmaceutical companies are dealing with an unprecedented volume of safety data with artificial intelligence moving from theoretical applications to practical solutions in pharmacovigilance. With the FDA now receiving over two …

Continue ›››

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 oncology approvals, including 11 for …

Continue ›››

What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025

In a rapidly evolving clinical research landscape, there is a greater need now more than ever for pharma and biotech companies to outsource trial management activities to contract research organizations …

Continue ›››

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

Legal and Governance Considerations in AI for Drug Discovery: New Paradigms and 2025 Outlook

Just in time for 2025 prediction season, a survey of the emerging AI drug discovery landscape, prepared by Chris Bradbury, has been making the rounds—and with good reason. The survey …

Continue ›››

The AI-driven Development Journey of ISM5411, a Potential Breakthrough Treatment for Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD), a chronic and debilitating autoimmune disorder that includes ulcerative colitis and Crohn’s disease, impacts millions of lives globally. Characterized by chronic gut inflammation, intestinal barrier dysfunction, …

Continue ›››

The Importance of Accurate Patient Matching for AI Projects

Artificial intelligence (AI) is revolutionizing healthcare by enhancing workflows, enabling earlier diagnoses, and paving the way for personalized care. However, its success depends on accurate patient matching, which ensures data …

Continue ›››

Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads

New research commissioned by ArisGlobal, a provider of life sciences technology solutions, reveals that surging regulatory workloads are forcing life sciences companies to prioritize advanced AI adoption in regulatory affairs …

Continue ›››